Recently, a great deal of studies have indicated that ILF2 was upregulated in numerous cancers, such as non-small cell lung cancer, gastric cancer and pancreatic carcinoma [16,19,47]. This evidence concerns the gene ILF2 and non-small cell lung carcinoma.